OBJECTIVES: This paper outlines the rationale and need for a conceptual framework
comprising a standard set of necessary indicators to assess performance in severe asthma …

OBJECTIVES: Despite recent advancements in the pharmacological management of severe
asthma (SA), there is a significant lack of robust, system level data on the diagnostic …

Severe asthma imposes a significant burden on individuals, families and the healthcare
system. Treatment is complex, due to disease heterogeneity, comorbidities and complexity …

Introduction: In spite of treatment advances, many asthma patients remain undertreated or
with reduced quality of life. A multi-country study was conducted to identify challenges …

Aim Severe asthma is a complex, heterogeneous condition that can be difficult to control
despite currently available treatments. Multidisciplinary severe asthma units (SAU) improve …

BACKGROUND Systematic assessment of severe asthma can be used to confirm the
diagnosis identify comorbidities, and address adherence to therapy. However, the …

Severe bronchial asthma affects at least 5% of the asthmatic population and remains a
clinical challenge. Data from the UK National Registry for Severe Asthma suggest that …

Background To improve access to severe asthma services across England, an
understanding of variation in delivery models, pathways and practice is critical. Aim This …

Severe asthma leads to debilitating symptoms for patients and excessive socioeconomic
burden for the community. Comprehensive models of care are required to address complex …

Introduction Severe asthma is a debilitating, life-threatening disease associated with
substantial global morbidity, mortality, and health care resource utilization. Patients may not …